From: Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study
Risk factors (p ≤ 0.05)
Odds Ratio
95% CI
Duration of stay
0.90
0.84–0.96
Long-term-dialysis
0.08
0.01–1.10
Flucloxacillin treatment
0.09
0.01–0.60
Piperacillin/tazobactam treatment
0.24
0.05–1.13